PROCEPT BioRobotics Corporation Common Stock
PRCTStockNASDAQ
$25.71 ▼ 7.17%
12 juin 2026
P
PROCEPT BioRobotics Corporation Common Stock
$25.71 ▼ 7.17%
12 juin 2026
PRCTStockNASDAQ

01 / À propos

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Arberion
Loading market data